< Back to previous page
Researcher
Kathleen Lambein
- Keywords:Medicine
- Disciplines:Morphological sciences, Oncology, Orthopaedics, Surgery, Nursing
Affiliations
- Surgical Oncology (Division)
Member
From15 Mar 2015 → Today
Projects
1 - 1 of 1
- Role of combined chemo- and immunotherapy in early breast cancerFrom1 Oct 2016 → 30 Sep 2020Funding: Nonprofit institution or equivalents
Publications
21 - 28 of 28
- Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype(2014)
Authors: Kathleen Lambein, Louis Libbrecht
Pages: 275 - 289 - 2013 Update of the American Society of Clinical Oncology/College of American Pathologists Guideline for Human Epidermal Growth Factor Receptor 2 Testing: Impact on Immunohistochemistry-Negative Breast Cancers(2014)
Authors: Kathleen Lambein, Louis Libbrecht
Pages: 1856 - 1857 - Differential regulation of extracellular matrix protein expression in carcinoma-associated fibroblasts by TGF-β1 regulates cancer cell spreading but not adhesion.(2014)
Authors: Kathleen Lambein, Ridha Limame, Louis Libbrecht
Pages: 634 - 648 - Stromal architecture and periductal decorin are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ of the breast(2013)
Authors: Kathleen Lambein, Louis Libbrecht
Pages: 520 - 533 - Distinguishing Score 0 From Score 1+in HER2 Immunohistochemistry-Negative Breast Cancer Clinical and Pathobiological Relevance(2013)
Authors: Kathleen Lambein, Louis Libbrecht
Pages: 561 - 566 - Analysis of microsatellite instability in gastric mucosa-associated lymphoid tissue lymphoma(2013)
Authors: Sara Vander Borght, Gert Matthijs, Louis Libbrecht, Kathleen Lambein, Gert De Hertogh, Thomas Tousseyn, Xavier Sagaert
Pages: 812 - 818 - Identification, validation and clinical implementation of cancer biomarkers: Translational strategies of the EORTC PathoBiology Group(2012)
Authors: Kathleen Lambein, Louis Libbrecht, Sabine Tejpar
Pages: 120 - 127 - Relationship between pathological features, HER2 protein expression and HER2 and CEP17 copy number in breast cancer: biological and methodological considerations(2011)
Authors: Kathleen Lambein, Louis Libbrecht
Pages: 200 - 207